Compounds > dermatan sulfate
Page last updated: 2024-08-23

dermatan sulfate and Nervous System Disorders

dermatan sulfate has been researched along with Nervous System Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kida, S; Kinoshita, M; Morimoto, H; Shibasaki, T; Tachibana, K; Tanaka, N; Yamamoto, R1
Adams, HP; Hansen, MD; Johnston, SC; Leira, EC1
Briani, C; Latov, N; Santoro, M1

Other Studies

3 other study(ies) available for dermatan sulfate and Nervous System Disorders

ArticleYear
Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
    Molecular genetics and metabolism, 2018, Volume: 125, Issue:1-2

    Topics: Animals; Biomarkers; Blood-Brain Barrier; Brain; Chromatography, Liquid; Dermatan Sulfate; Disease Models, Animal; Heparitin Sulfate; Humans; Iduronate Sulfatase; Mice; Mice, Knockout; Mucopolysaccharidosis II; Nervous System Diseases; Receptors, Transferrin; Tandem Mass Spectrometry

2018
Early recovery after cerebral ischemia risk of subsequent neurological deterioration.
    Annals of neurology, 2003, Volume: 54, Issue:4

    Topics: Aged; Anticoagulants; Blood Glucose; Blood Pressure; Case-Control Studies; Chondroitin Sulfates; Dermatan Sulfate; Disease Progression; Drug Combinations; Female; Follow-Up Studies; Heart Rate; Heparitin Sulfate; Humans; Ischemic Attack, Transient; Male; Middle Aged; Nervous System Diseases; Neurologic Examination; Odds Ratio; Randomized Controlled Trials as Topic; Recovery of Function; Risk; Time Factors

2003
Antibodies to chondroitin sulfates A, B, and C: clinico-pathological correlates in neurological diseases.
    Journal of neuroimmunology, 2000, Aug-01, Volume: 108, Issue:1-2

    Topics: Absorption; Antibodies; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Immune Sera; Motor Neuron Disease; Multiple Sclerosis; Myelitis; Nervous System Diseases; Statistics as Topic; Sulfoglycosphingolipids

2000